MTOR and acute myeloid leukemia: By combining these models with the PI3K inhibitor LY294002 [19], we demonstrate for the first time that DC-STAMP suppresses PANoptosis and promotes AML cell survival and drug resistance through activation of the PI3K/AKT/mTOR signaling pathway.